Features of innate and adaptive immunity in patients with COVID-19 coronavirus infection
https://doi.org/10.21886/2219-8075-2025-16-1-106-111
Abstract
Objective: to study the immunological parameters of patients who had suffered from COVID-19 in moderate form 1 and 6 months after recovery. Materials and methods: 60 patients hospitalized with the diagnosis of "COVID-19, moderate form; complication: interstitial pneumonia" were examined. Immunological parameters were assessed 1 month and 6 months after recovery. Comparison group: 20 healthy volunteers. Results: after six months, signs of immune dysfunction continue to persist in the immune status, consisting in a violation of the processes of differentiation and proliferation of immunocompetent cells. Conclusion: the need for immunological monitoring in people who have had COVID-19 for 6 months in order to identify immunodeficiency conditions and prevent infectious diseases against this background is shown.
About the Authors
L. P. SizyakinaRussian Federation
Lyudmila P. Sizyakina, Dr. Sci. (Med.), Prof., Head of the Clinical Immunology and Allergology Chair
Rostov-on-Don
Competing Interests:
Authors declare no conflict of interest
N. A. Skripkina
Russian Federation
Nadezhda A. Skripkina, head of the infectious diseases department No.4
Rostov-on-Don
Competing Interests:
Authors declare no conflict of interest
V. Ya. Zakurskaya
Russian Federation
Vita Ya. Zakurskaya, assistant of the Department of Clinical Immunology and Allergology
Rostov-on-Don
Competing Interests:
Authors declare no conflict of interest
D. V. Sizyakin
Russian Federation
Dmitry V. Sizyakin, Dr. Sci. (Med.), Prof., urology Chair, Rostov State Medical university; chief medical officer
Rostov-on-Don
Competing Interests:
Authors declare no conflict of interest
References
1. A clinical case definition of post COVID-19 condition by a Del phi consensus. wHO reference number: wHO/2019-nCoV/ Post_COVID-19_condition/Clinical_case_definition/2021.1
2. Chippa V, Aleem A, Anjum F. Postacute Coronavirus (CO VID-19) Syndrome. 2024. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. PMID: 34033370.
3. Altmann DM, Boyton RJ. Decoding the unknowns in long covid. BMJ. 2021;372:n132. https://doi.org/10.1136/bmj.n132
4. Gulyaev P.V., Resnyanskaya S.V., Ostrovskaya I.V. Detec tion of post-coronavirus syndrome in patients who have had a new coronavirus infection. Current problems of health care and medical statistics. 2022;(2):107-128. (In Russ.) https://doi.org/10.24412/2312-2935-2022-2-107-128
5. Andreev A.I., Andreev I.V., Nechay K.O., Esaulova D.R., Bak lakova O.S., et al. Сorrelation between age and the intensity of the post-vaccination humoral immune response in individ uals passed COVID-19. Immunologiya. 2022;43(5):583–592. (In Russ.) https://doi.org/10.33029/0206-4952-2022-43-5-583-592.
6. Huang C, Huang L, wang Y, Li x, Ren L, et al. 6-month con sequences of COVID-19 in patients discharged from hospi tal: a cohort study. Lancet. 2023;401(10393):2025. https://doi.org/10.1016/S0140-6736(23)01175-3
7. Skripkina N.A., Sizyakin D.V., Antonova E.A. Clinical and immunological characteristics of patients with moderate CO VID-19 with different lung lesion areas. Medical Herald of the South of Russia. 2023;14(4):22-28. (In Russ.) https://doi.org/10.21886/2219-8075-2023-14-4-22-28.
8. Inyutkina A.A., Nikulina V.P., Godkov M.A. Features of the Immune Response in COVID-19. Russian Sklifosovsky Jour nal "Emergency Medical Care". 2023;12(1):122-129. (In Russ.) https://doi.org/10.23934/2223-9022-2023-12-1-122-129
Review
For citations:
Sizyakina L.P., Skripkina N.A., Zakurskaya V.Ya., Sizyakin D.V. Features of innate and adaptive immunity in patients with COVID-19 coronavirus infection. Medical Herald of the South of Russia. 2025;16(1):106-111. (In Russ.) https://doi.org/10.21886/2219-8075-2025-16-1-106-111